Circulating Tumour Cells: A Powerful Tool for Real-Time Target Assessment & Strategic Development of ADCs in Cancer Therapy
3:00 pm - Tuesday 24th February 2026
- Outlining the role of CTCs in liquid biopsy: Overviewing circulating tumour cells as accessible, dynamic biomarkers in oncology
- Discussing target antigen expression on CTCs: Evaluating ADC-relevant targets (e.g., HER2, TROP2) in real-time to guide therapy selection
- Exploring the potential role of CTC profiling in ADC clinical trials and practice
